Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter

S Cointe1,2, C Judicone2,3, S Robert1

  • 1VRCM, UMR-S1076, Aix-Marseille Université, INSERM, UFR de Pharmacie, Marseille, France.

Insights

Standardizing microparticle (MP) counts using flow cytometry is crucial for their clinical use. A multicenter study showed that bead-based standardization effectively reduced variability across different instruments, paving the way for reliable MP biomarker development.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Cell Biology

Background:

  • Microparticles (MPs) are extracellular vesicles with biomarker potential.
  • Clinical utility of MPs is limited by inconsistent enumeration methods.
  • Flow cytometry (FCM) is standard for MP analysis but lacks instrument standardization.

Purpose of the Study:

  • To evaluate a novel bead-based strategy for standardizing microparticle enumeration by FCM.
  • To assess the reproducibility of MP counts across diverse FCM platforms in a multicenter setting.

Main Methods:

  • An international workshop involved 44 laboratories and 52 cytometers.
  • A standardization strategy using specific beads for FSC or SSC-optimized instruments was tested.
  • Instrument compatibility was assessed using resolution capability and background noise.

Main Results:

  • The bead-based standardization strategy was compatible with 85% of the tested instruments.
  • All instruments accurately ranked platelet-derived MP (PMP) levels in plasma samples.
  • Inter-laboratory variability for PMP counts was reduced to 37% and 28%.

Conclusions:

  • Bead-based strategies show significant potential for standardizing MP enumeration across different FCM platforms.
  • This approach offers a viable solution to overcome variability in MP counts.
  • Further standardization efforts are necessary for multicenter clinical validation of MPs.